Common tax questions FOX21 News, dedicated to providing relevant news, information and weather to Southern Colorado. Go to http://FOX21news.com for the latest. By: FOX21NewsColorado … Continue reading →

Exercise is Medicine at the University of South Florida By: wellnessusf … Continue reading →

Mar. 26, 2013 A proof-of-concept study suggests the possibility of engineering artificial ovaries in the lab to provide a more natural option for hormone replacement therapy for women. In Biomaterials, a team from Wake Forest Baptist Medical Center's Institute for Regenerative Medicine report that in the laboratory setting, engineered ovaries showed sustained release of the sex hormones estrogen and progesterone. Although there are medications that can compensate for the loss of female sex hormone production, the drugs are often not recommended for long-term use due to the increased risk of heart disease and breast cancer. "Our goal is to develop a tissue- or cell-based hormone therapy -- essentially an artificial ovary- to deliver sex hormones in a more natural manner than drugs," said Emmanuel C. Opara, Ph.D., professor of regenerative medicine and senior author. "A bioartificial ovary has the potential to secrete hormones in a natural way based on the body's needs, rather than the patient taking a specific dose of drugs each day." Ovaries are the female reproductive organs that produce eggs that are fertilized for pregnancy as well as secrete hormones important to bone and cardiovascular health. The loss of ovarian function can be due to surgical removal, … Continue reading →

A proof-of-concept study suggests the possibility of engineering artificial ovaries in the lab to provide a more natural option for hormone replacement therapy for women. A team from Wake Forest Baptist Medical Center's Institute for Regenerative Medicine report that in the laboratory setting, engineered ovaries showed sustained release of the sex hormones estrogen and progesterone. The study was published in the journal Biomaterials. A release from the center notes that although there are medications that can compensate for the loss of female sex hormone production, the drugs are often not recommended for long-term use due to the increased risk of heart disease and breast cancer. Senior author Emmanuel C. Opara, Ph.D. is quoted as saying, "Our goal is to develop a tissue- or cell-based hormone therapy essentially an artificial ovary to deliver sex hormones in a more natural manner than drugs. A bioartificial ovary has the potential to secrete hormones in a natural way based on the body's needs, rather than the patient taking a specific dose of drugs each day." Copyright 1997 - 2013 ThirdAge Media, LLC. All rights reserved. View original post here: Toward a Natural HRT … Continue reading →

Bioartificial Ovary May One Day Provide Natural Hormone Replacement Therapy Newswise WINSTON-SALEM, N.C. March 26, 2013 A proof-of-concept study suggests the possibility of engineering artificial ovaries in the lab to provide a more natural option for hormone replacement therapy for women. In Biomaterials, a team from Wake Forest Baptist Medical Centers Institute for Regenerative Medicine report that in the laboratory setting, engineered ovaries showed sustained release of the sex hormones estrogen and progesterone. Although there are medications that can compensate for the loss of female sex hormone production, the drugs are often not recommended for long-term use due to the increased risk of heart disease and breast cancer. Our goal is to develop a tissue- or cell-based hormone therapy essentially an artificial ovary to deliver sex hormones in a more natural manner than drugs, said Emmanuel C. Opara, Ph.D., professor of regenerative medicine and senior author. A bioartificial ovary has the potential to secrete hormones in a natural way based on the bodys needs, rather than the patient taking a specific dose of drugs each day. Ovaries are the female reproductive organs that produce eggs that are fertilized for pregnancy as well as secrete hormones important to bone and cardiovascular … Continue reading →

Public release date: 27-Mar-2013 [ | E-mail | Share ] Contact: Tim Wall walltj@missouri.edu 573-882-3346 University of Missouri-Columbia More than 100 women per day die from breast cancer in the United States. The odds of developing breast cancer increase for women taking hormone replacement therapy to avoid the effects of menopause. New research by University of Missouri scientist Salman Hyder may lead to treatments for breast cancers associated with taking these synthetic hormones. Hyder, along with an international team, found that hormone-therapy-related breast cancer cells have a physical feature that could be attacked by cancer therapies. "We identified a specific cell membrane protein that blocks cell death in breast cancer cells and allows these cells to grow in response to hormone replacement therapy," said Hyder. "Others have observed an over-abundance of these proteins in a population of breast cancer cells which may explain increased risk of breast cancer in women who consume hormone replacement therapy. Therapies could be developed that would block the activity of these cell membrane proteins, which would make cancer cells more likely to die. The membrane protein is known as PGRMC1." The proteins identified by Hyder and his colleagues were affected by progestin, one of the … Continue reading →